How can controlled human infection models accelerate clinical development and policy pathways for vaccines against Shigella?

Birgitte K. Giersing*, Chad K. Porter, K. Kotloff, Pieter Neels, Alejandro Cravioto, Calman A. MacLennan

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

24 Scopus citations

Fingerprint

Dive into the research topics of 'How can controlled human infection models accelerate clinical development and policy pathways for vaccines against Shigella?'. Together they form a unique fingerprint.

Medicine & Life Sciences

Agriculture & Biology

Social Sciences